These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3001890)

  • 1. [Dazoxiben blocks the increase of angiotensin converting enzyme in bronchoalveolar lavage induced by free fatty acids].
    Espinoza X; Donoso P; González MC; Oyarzún M
    Rev Med Chil; 1985 Jan; 113(1):6-11. PubMed ID: 3001890
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboxane mediates the increase in alveolar surfactant pool induced by free fatty acid infusion in the rabbit.
    Oyarzún MJ; Donoso P; Arias M; Quijada D
    Respiration; 1984; 46(2):231-40. PubMed ID: 6436937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of free fatty acid infusion on rabbit pulmonary surfactant. Influence of corticosteroids.
    Oyarzun MJ; Cabezas E; Donoso P; Quijada D
    Bull Eur Physiopathol Respir; 1984; 20(2):105-11. PubMed ID: 6426555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of bleomycin lung toxicity using angiotensin-converting enzyme in pulmonary lavage.
    Newman RA; Kimberly PJ; Stewart JA; Kelley J
    Cancer Res; 1980 Oct; 40(10):3621-6. PubMed ID: 6159967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation.
    Grimminger F; Mayer K; Krämer HJ; Stevens J; Walmrath D; Seeger W
    J Pharmacol Exp Ther; 1993 Oct; 267(1):259-65. PubMed ID: 8229753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Tilton GD; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1983; 96():103-12. PubMed ID: 6687298
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of acute lung injury on angiotensin converting enzyme in serum, lung lavage, and effusate.
    Hollinger MA; Giri SN; Patwell S; Zuckerman JE; Gorin A; Parsons G
    Am Rev Respir Dis; 1980 Feb; 121(2):373-6. PubMed ID: 6244767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The course of the pulmonary changes in postraumatic shock (shock-lung) (author's transl)].
    Haider W; Baum M; Benzer H; Lackner F
    Anaesthesist; 1974 Mar; 23(3):129-36. PubMed ID: 4480426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical and physiological activity of new peptide inhibitors of angiotensin-converting enzyme].
    Gomazkov OA; Pozdnev VF; Kalinina EV; Komissarova NV; Medvedeva NA; Nesterova MA; Petriĭ OP
    Biull Eksp Biol Med; 1996 Sep; 122(9):279-81. PubMed ID: 8974479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood kinin system and pulmonary surfactant in peritonitis].
    Ivashkevich NG; Khimka AS
    Vestn Khir Im I I Grek; 1983 Jun; 130(6):56-8. PubMed ID: 6310844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of thromboxane synthetase with dazoxiben - basis of its inhibitory effect on platelet adhesion.
    Menys VC; Davies JA
    Thromb Haemost; 1983 Apr; 49(2):96-101. PubMed ID: 6346575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of angiotensin-converting enzyme inhibitor, foroxymithine, on dynamic equilibrium around the renin-angiotensin system in vivo.
    Aoyagi T; Wada T; Iinuma H; Ogawa K; Kojima F; Nagai M; Kuroda H; Obayashi A; Umezawa H
    J Appl Biochem; 1985 Dec; 7(6):388-95. PubMed ID: 3007425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric oxygen toxicity: role of thromboxane.
    Jacobson JM; Michael JR; Meyers RA; Bradley MB; Sciuto AM; Gurtner GH
    J Appl Physiol (1985); 1992 Feb; 72(2):416-22. PubMed ID: 1559913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-blood assays for evaluation of thromboxane synthase inhibition.
    Spokas EG; Nicholson NS; Suleymanov OD; Walsh GM; Tuffin D
    Methods Mol Biol; 1999; 120():249-56. PubMed ID: 10343321
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin converting enzyme and endotoxin induced lung damage in the mouse.
    Cookson WO; Wiseman MS; Shale DJ
    Thorax; 1985 Oct; 40(10):774-7. PubMed ID: 2997946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.